The Knoblich Lab Profile picture
Research group @IMBA_Vienna and the @viennabiocenter.
Oct 30, 2020 11 tweets 6 min read
1/11: Interested in genetic screening in #organoids? Check out #CRISPRLICHT 💡, our method for loss-of-function screening in cerebral organoids 🧠 out now in @ScienceMagazine. By @christopher_esk and @DLindenhofer. Short thread.
science.sciencemag.org/content/early/… 2/11: Screening in organoids is difficult because just like animal tissue - but unlike 2D cells - cerebral organoid tissue grows unequally, masking potential loss of function effects.
Sep 10, 2020 12 tweets 5 min read
1/12 Check our latest work led by our Postdoc @fbonnay_vienna where we describe a fundamental role of mitochondrial fusion and oxidative metabolism for tumor cell immortalization, in the larval brain of #Drosophila melanogaster. sciencedirect.com/science/articl… 2/12 Our tumor model of choice is derived from asymmetrically dividing neural stem cells (NSCs) called type II Neuroblasts, deficient for the tumor suppressor gene brain tumor or brat. brat-deficient type II Neuroblasts give rise to big and lethal brain tumors.